Search Medications

Find medications, analyze interactions, and get AI-powered insights

Start typing to search through thousands of medications

Popular Treatments
1
tacrolimus

Prevention of organ rejection (kidney, liver, heart)

ID: CID100005372

2
citalopram

Major Depressive Disorder

ID: CID100002771

3
pimecrolimus

Atopic Dermatitis (Eczema)

ID: CID103055172

4
doxorubicin

Breast cancer

ID: CID100001690

5
docetaxel

Breast cancer, Lung cancer, Prostate cancer, Stomach cancer, Head and neck cancer

ID: CID100003143

6
topiramate

Epilepsy (partial-onset or primary generalized tonic-clonic seizures)

ID: CID100005514

7
imatinib

Chronic Myeloid Leukemia (CML)

ID: CID100005291

8
risperidone

Schizophrenia

ID: CID100005073

9
paroxetine

Major Depressive Disorder

ID: CID100004691

10
quetiapine

Schizophrenia

ID: CID100005002

11
paclitaxel

Ovarian cancer

ID: CID100004666

12
estradiol

Menopausal symptoms (hot flashes, night sweats, vaginal dryness)

ID: CID100003267

13
LY146032

Hypercholesterolemia

ID: CID116129629

14
pregabalin

Neuropathic pain associated with diabetic peripheral neuropathy

ID: CID100125889

15
methylphenidate

ADHD

ID: CID100004158

16
everolimus

Prevention of organ rejection following kidney, liver, or heart transplantation

ID: CID106442177

17
tramadol

Moderate to moderately severe pain

ID: CID100005523

18
bupropion

Major Depressive Disorder

ID: CID100000444

19
gabapentin

Postherpetic neuralgia

ID: CID100003446

20
ribavirin

Chronic Hepatitis C

ID: CID100005064

Latest Treatments
1

selinexor

Multiple myeloma (relapsed/refractory)

ID: CID71481097

2

sacituzumab govitecan

Metastatic triple-negative breast cancer (TNBC) in patients who have received at least two prior therapies for metastatic disease.

ID: CID91668186

3

margetuximab

HER2-positive metastatic breast cancer

ID: NOT_FOUND

4

belantamab mafodotin

Relapsed/refractory multiple myeloma in patients who have received at least four prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent

ID: NOT_FOUND

5

lurbinectedin

Small cell lung cancer (SCLC) in combination with doxorubicin in adult patients with disease progression after one prior platinum-based line of chemotherapy

ID: CID57327016

6

tazemetostat

Epithelioid sarcoma

ID: CID66558664

7

ripretinib

Advanced gastrointestinal stromal tumor (GIST) with a PDGFRA exon 18 mutation including PDGFRA D842V mutations after prior treatment with imatinib and sunitinib

ID: CID71584930

8

avapritinib

Advanced systemic mastocytosis (AdvSM)

ID: CID118023034

9

asciminib

Chronic myeloid leukemia (CML) in chronic phase previously treated with two or more tyrosine kinase inhibitors (TKIs)

ID: CID72165228

10

pemigatinib

Cholangiocarcinoma (bile duct cancer) with FGFR2 fusion or rearrangement

ID: CID86705695

11

tepotinib

Non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations

ID: CID25171648

12

inebilizumab

Neuromyelitis optica spectrum disorder (NMOSD)

ID: NOT_FOUND

13

satralizumab

Neuromyelitis optica spectrum disorder (NMOSD)

ID: NOT_FOUND

14

evinacumab

Homozygous familial hypercholesterolemia (HoFH)

ID: NOT_FOUND

15

casimersen

Duchenne muscular dystrophy (DMD) amenable to exon 45 skipping

ID: NOT_FOUND

16

viltolarsen

Duchenne muscular dystrophy (DMD) amenable to exon 53 skipping

ID: NOT_FOUND

17

lumasiran

Primary hyperoxaluria type 1 (PH1)

ID: NOT_FOUND

18

trilaciclib

Reduction of the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer (ES-SCLC)

ID: CID68029831

19

tucatinib

HER2-positive breast cancer (unresectable or metastatic)

ID: CID51039094

20

pralsetinib

RET fusion-positive non-small cell lung cancer (NSCLC)

ID: CID129073603